A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetics, and anti-tumor efficacy
of ocrelizumab in participants with progressive follicular NHL.